[go: up one dir, main page]

MXPA02012378A - Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro. - Google Patents

Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.

Info

Publication number
MXPA02012378A
MXPA02012378A MXPA02012378A MXPA02012378A MXPA02012378A MX PA02012378 A MXPA02012378 A MX PA02012378A MX PA02012378 A MXPA02012378 A MX PA02012378A MX PA02012378 A MXPA02012378 A MX PA02012378A MX PA02012378 A MXPA02012378 A MX PA02012378A
Authority
MX
Mexico
Prior art keywords
vitro
vivo
follicular growth
nucleotide
amino acid
Prior art date
Application number
MXPA02012378A
Other languages
English (en)
Inventor
Kaisa Niina Johann Vuojolainen
Original Assignee
Agres Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agres Ltd filed Critical Agres Ltd
Publication of MXPA02012378A publication Critical patent/MXPA02012378A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo o in vitro. La presente invencion tambien se relaciona con polipeptidos homodimericos y heterodimericos novedosos y su uso para alterar el crecimiento folicular ovarico de mamifero in vivo o in vitro. En particular, la invencion se relaciona ampliamente con la inmunizacion activa o pasiva contra estos polipeptidos horno- o heterodimericos o fragmentos o variantes funcionales de los mismos, para alterar el crecimiento folicular in vivo o in vitro.
MXPA02012378A 2000-06-15 2001-06-15 Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro. MXPA02012378A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ502796A NZ502796A (en) 2000-06-15 2000-06-15 Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
PCT/NZ2001/000113 WO2001096393A2 (en) 2000-06-15 2001-06-15 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro

Publications (1)

Publication Number Publication Date
MXPA02012378A true MXPA02012378A (es) 2004-09-10

Family

ID=19927744

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012378A MXPA02012378A (es) 2000-06-15 2001-06-15 Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.

Country Status (12)

Country Link
US (2) US7098183B2 (es)
EP (1) EP1294755A2 (es)
JP (1) JP2004503236A (es)
CN (1) CN1294143C (es)
AU (1) AU784276C (es)
BR (1) BR0111685A (es)
CA (1) CA2410532A1 (es)
MX (1) MXPA02012378A (es)
NZ (1) NZ502796A (es)
RU (1) RU2270862C2 (es)
WO (1) WO2001096393A2 (es)
ZA (1) ZA200210122B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
EP1522311A1 (fr) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée
US20060234274A1 (en) * 2005-03-29 2006-10-19 Auckland Uniservices Limited Methods of diagnosis
JP2009501533A (ja) * 2005-07-18 2009-01-22 アデレード リサーチ アンド イノベイション ピーティーワイ エルティーディー 顆粒膜細胞アポトーシスの調節
CN101525662B (zh) * 2009-04-02 2011-08-17 西北农林科技大学 一种用gdf5基因预示和鉴定秦川牛体尺大小的分子标记方法
CN108977553B (zh) * 2018-09-05 2021-08-31 湖北省农业科学院畜牧兽医研究所 蛋鸭环状RNA circ_13267及其检测试剂、方法与应用
CN108977554B (zh) * 2018-09-05 2021-08-31 湖北省农业科学院畜牧兽医研究所 蛋鸭环状RNA circ_13034及其检测试剂、方法与应用
CN116102620A (zh) * 2022-12-07 2023-05-12 童国庆 卵泡液来源的多肽、化学合成物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030617A (en) * 1993-01-12 2000-02-29 The Johns Hopkins University School Of Medicine Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
US5821056A (en) * 1993-01-12 1998-10-13 The Johns Hopkins University School Of Medicine Growth differentiation factor-9
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
DE69821629T2 (de) * 1997-09-19 2005-01-13 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Kombinationen von Cytokinen mit neurotroper Aktivität
US6872698B2 (en) * 1998-07-06 2005-03-29 Scion Pharmaceuticals, Inc. Methods for treating neurological injuries and disorders
PT1135154E (pt) * 1998-12-01 2003-08-29 Akzo Nobel Nv Melhoria da foliculogenese
NZ500844A (en) * 2000-05-05 2003-06-30 Agres Ltd Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate

Also Published As

Publication number Publication date
AU784276B2 (en) 2006-03-02
BR0111685A (pt) 2007-05-29
ZA200210122B (en) 2003-09-30
CN1294143C (zh) 2007-01-10
RU2003100883A (ru) 2005-01-20
WO2001096393A3 (en) 2002-08-08
EP1294755A2 (en) 2003-03-26
WO2001096393A2 (en) 2001-12-20
WO2001096393A9 (en) 2002-11-28
JP2004503236A (ja) 2004-02-05
NZ502796A (en) 2003-02-28
US20040267003A1 (en) 2004-12-30
US20060253912A1 (en) 2006-11-09
AU6795001A (en) 2001-12-24
AU784276C (en) 2007-11-15
RU2270862C2 (ru) 2006-02-27
CN1636012A (zh) 2005-07-06
US7098183B2 (en) 2006-08-29
CA2410532A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
BRPI9909018B8 (pt) processo para a síntese de um peptídeo
IN2015DN02553A (es)
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
MY162525A (en) Process for concentration of antibodies and therapeutic products thereof
ATE299029T1 (de) Verfahren und zusammensetzungen zur peptidsynthese (t-20)
WO2001005810A3 (de) CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?
MXPA02012378A (es) Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
ATE495247T1 (de) Chromoprotein und fluoroproteine
WO2003008449A8 (en) Ntb-a, a surface molecule involved in natural killer cells activity
IL156640A (en) Process for preparing arylethanoldiamines from imidazooxazoles, starting material and intermediate used in the process
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
WO2004058810A3 (en) Crystal structures of nh3-dependent nad synthetases
WO2003087352A3 (en) Enolase polypeptides and structures
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2004069989A3 (en) Novel purified phosphodiesterase polypeptides
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases
WO2003048358A1 (fr) Gene et proteine associes a la differenciation adipocytaire
WO2004042044A3 (en) Crystal structures of bacterial guanylate kinases
WO2000061750A3 (en) TYROSINE KINASE SUBSTRATE (Tks) PROTEINS